As the global HIV response faces rising risks, UNAIDS shifts to a leaner, sharper model focused on country impact . GENEVA, 10 May 2025—In the face of continued high numbers of ...

Producer Vivien Schütz presents the story of Gina Velasquez, who progressively lost her vision due to an HIV/AIDS diagnosis ...

Modern HIV medicine is based on a common genetic mutation. Now, researchers have traced where and when the mutation arose -- and how it protected our ancestors from ancient diseases.

Updated recommendations for antiretroviral nonoccupational postexposure prophylaxis (nPEP) for HIV have been published in the ...

I am writing to draw attention to a pressing issue that continues to affect HIV-positive individuals. The inadequacy of ...

Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.

A panelist discusses how the new doravirine and islatravir combination offers an alternative to integrase inhibitor-based ...

A panelist discusses how a new drug combination of doravirine and islatravir was compared to a standard bictegravir-based ...

In the hunt for a remedy, when the baton is passed from dedicated academic scientists to an innovative company to trusted community advocates, outcomes for society can be especially powerful.

A disruption in federal funds has jeopardized HIV testing and outreach in Mississippi, and researchers warn of a resurgence of the epidemic.